uniQure plans BLA submission for Huntington's therapy in Q3 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to uniQure plans BLA submission for Huntington's therapy in Q3 2026
UNIQURE (NASDAQ: QURE) Delayed: 44.09 +1.60 (3.77%)
Previous Close $42.49    52 Week High $22.79 
Open $43.47    52 Week Low $6.63 
Day High $44.58    P/E N/A 
Day Low $43.00    EPS $0.00 
Volume 675,907